𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma

✍ Scribed by Dwayne Collier; Mark S. Soloway

Book ID
119043018
Publisher
Elsevier Science
Year
1976
Tongue
English
Weight
698 KB
Volume
8
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cyclophosphamide versus cyclophosphamide
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: A randomized trial
✍ Hyman B. Muss; Virginia Howard; Frederick Richards Ii; Douglas R. White; Don V. πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 364 KB πŸ‘ 1 views

Thirty-two evaluable patients with metastatic carcinoma of the prostate were entered into a prospective randomized trial comparing cyclophosphamide (CYC) with a combination of cyclophosphamide, methotrexate, and fluorouracil (CMF). Progressive disease after endocrine manipulation was noted in 97% (3

A prospective, randomized phase III tria
A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma
✍ Cesar Blajman; L. Balbiani; J. Block; F. Coppola; R. Chacon; L. Fein; S. Bonicat πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 105 KB πŸ‘ 2 views

## Background: A prospective, multicenter, randomized, phase iii trial comparing the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide (fac) with a combination of vinorelbine and doxorubicin (na) in the treatment of patients with advanced breast carcinoma w

A combination of 5-fluorouracil and thym
A combination of 5-fluorouracil and thymidine in advanced colorectal carcinoma
✍ Ahud Sternberg; Nicholas J. Petrelli; Jesse Au; Youcef Rustum; Arnold Mittelman; πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 457 KB

Concurrent administration of thymidine (TdR) has been shown to increase the antitumor activity of 5-fluorouracil (5-FU) in various experimental models. The clinical response rate, side-effects, and toxicity of 5-FU and TdR were evaluated in 27 patients with advanced colorectal carcinomas. Each 6-day